Hepato-Pancreato-Biliary Surgery
141 – 150 of 177
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Factors influencing receipt of adjuvant chemotherapy after surgery for pancreatic cancer : a two-center retrospective cohort study
(
- Contribution to journal › Article
-
Mark
Development and In Vitro Characterization of a Gemcitabine-loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Routine intraoperative cholangiography during cholecystectomy is a cost-effective approach when analysing the cost of iatrogenic bile duct injuries
(
- Contribution to journal › Article
-
Mark
Pankreascancer kan metastasera tidigt : Tumörbiologi tycks viktigare än tumörstorlek
(
- Contribution to journal › Article
-
Mark
Liver tissue characterization and influence of chemotherapy in liver surgery
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Scientific review
-
Mark
Intraductal papillary mucinous neoplasm of the pancreas–epidemiology, risk factors, diagnosis, and management
(
- Contribution to journal › Scientific review
-
Mark
Endoscopic classification of the papilla of Vater. Results of an inter- and intraobserver agreement study
(
- Contribution to journal › Article
-
Mark
Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine
(
- Contribution to journal › Article